TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05732376

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nasopharyngoscopic Velopharyngeal Training with 3D Printed Endoscopy Training Model
Description: Theoretical training: The theoretical training covers the anatomy and physiology of the velopharyngeal region and nasal cavity, nasopharyngoscope, preparation of the patient for nasopharyngoscopy, use of the endoscope during nasopharyngoscopy and the procedure for nasopharyngoscopic velopharyngeal function assessment.~Practical training: At the beginning of the hands-on training, the device will be introduced to the participants. Basic information will be given about endoscopy device. Then, the principal investigator will give information about the use of the endoscope (patient instructions, holding the endoscope, placement of the endoscope in the nose, manipulation of the endoscope, anatomical structures in the nasal cavity and velopharyngeal region, velopharyngeal function assessment) on the 3D printed endoscopy training model. Participants will receive hands-on training on the 3D printed endoscopy training model, under the guidance of the principal investigator.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nasopharyngoscopic Velopharyngeal Training with Ready-Made Endoscopy Training Model
Description: Theoretical training: The theoretical training covers the anatomy and physiology of the velopharyngeal region and nasal cavity, nasopharyngoscope, preparation of the patient for nasopharyngoscopy, use of the endoscope during nasopharyngoscopy and the procedure for nasopharyngoscopic velopharyngeal function assessment.~Practical training: At the beginning of the hands-on training, the device will be introduced to the participants. Basic information will be given about endoscopy device. Then, the principal investigator will give information about the use of the endoscope (patient instructions, holding the endoscope, placement of the endoscope in the nose, manipulation of the endoscope, anatomical structures in the nasal cavity and velopharyngeal region, velopharyngeal function assessment) on the ready-made endoscopy training model. Participants will receive hands-on training on the ready-made endoscopy training model, under the guidance of the principal investigator.
Study: NCT05739318

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The cuff of endotracheal and endobronchial is collapsed
Description: The diameter of double-lumen tube at the cuff of endotracheal and endobronchial when the cuff is collapsed as the diameter of double-lumen tube and select a double-lumen tube that matches the patient's trachea and bronchial innerdiameter based on this diameter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The cuff of endotracheal and endobronchial is inflated
Description: The diameter of double-lumen tube at the cuff of endotracheal and endobronchial when the cuff is inflated as the diameter of double-lumen tube and select a double-lumen tube that matches the patient's trachea and bronchial innerdiameter based on this diameter
Study: NCT06216418

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BRFS-18G-S100WH
Description: A facial tissue fixation material made of polydioxanone (PDO).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MINT Lift FINE+
Description: A facial tissue fixation material made of polydioxanone (PDO).
Study: NCT06125093

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incredible Years Autism Spectrum and Language Delays Parent Program (IY-ASLD®)
Description: The IY-ASLD® program is a weekly group-based intervention for parents of children presenting neurodevelopmental problems (ASD symptoms, communication or language difficulties). The group is formed by 6-10 parents, and it is led by a group leader and a co-therapist, trained in the model.~The intervention is manualized. It includes video modelling and emphasizes the importance of practice-based learning through role-playing. The IY-ASLD® program takes into consideration the different developmental levels of each child and pairs parents according to this variable in role-play and other one-to-one discussions. Weekly home tasks will be assigned to parents, and families will be phoned each week to encourage home-based practice.~The intervention will be conducted online. Even though the IY-ASLD® original intervention comprises 14 sessions, the online format requires 22 weekly sessions.~Fidelity to the intervention will be assessed in accordance with the regulations of the program.
Study: NCT05737862

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: iron and folic acid supplements
Description: In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: iron and folic acid supplements
Description: In this arm, pregnant mothers receive IFA tablets 2 × 1 tablet a day for 30 days. Each IFA tablet contains 400 mcg folic acid and 180 mg Ferrous Fumarate.
Study: NCT05294861

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: YesMdiet
Description: In the YesMdiet, participants will consume Milk and Dairy products

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NoMdiet
Description: In the YesMdiet, participants will not consume Milk and Dairy products, only other sources of protein
Study: NCT06086379

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training for COVID-19
Description: CCT-C is a manualized group-based behavioral intervention (10 weeks, 2 hours per week, 20 hours total) designed to improve cognition and everyday functioning in patients with prolonged COVID-19 symptoms

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Holistic Cognitive Education
Description: HCE provides the same frequency and amount of therapist and other group member contact as CCT-C, but does not provide training in cognitive or lifestyle strategies addressed in CCT-C. The HCE intervention provides information and discussion regarding common causes of and treatments for cognitive impairment.
Study: NCT05991310

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine Assessment by Remote Neurologist
Description: Use of a telemedicine platform for a neurologist, remotely located, to assess a MSU patient, review imaging, and decide on the required treatments.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: In-Person Assessment by an Onboard Neurologist
Description: Traditional in-person assessment of a patient by a neurologist located onboard the MSU
Study: NCT05265702

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive Neuromodulation
Description: The electrodes will be placed with the help of gloves and adapted socks for 1 hour, twice a week, until 12 intervention sessions are completed. In addition, depending on the session, an adhesive electrode will be placed at the level of C7. Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.3 s and pause of 300 ms, voltage 3 millivolt and intensity 0.5 μA.
Study: NCT05606601

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Minder
Description: There are four main components of the Minder app: The Chatbot, Services, Community, and Peer Coaching components. The Services component asks participants to complete a series of questions on various mental health, substance use, and general life issues. It then recommends community and on-campus resources based on their current needs. The Community component of the app matches individuals with groups (e.g., student clubs) and events at the university or in the broader community that they may be interested in. The Chatbot component of the app contains pre-formatted conversational scripts that users engage with via a chatbot and videos designed to teach evidence-based skills (e.g., cognitive strategies to manage anxiety) that can be applied to everyday life. To support use of the app, all users in the intervention group will be offered access to trained peer coaches to help users navigate the different app components and provide non-clinical peer support.
Study: NCT05455034

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: single-cell sequencing
Description: Treatment is given according to the results of single-cell sequencing.

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: single-cell sequencing
Description: Treatment is given according to the results of single-cell sequencing.
Study: NCT05804318

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Daily adaptive SBRT with urethral sparing
Description: The radiation plan for each daily fraction is adapted from the initial plan based on cone beam CT imaging acquired while the participant is laying on the treatment machine.
Study: NCT06330376

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care of traditional treatment
Description: Usual care of traditional treatment which is PT and/or OT when indicated Followed by Pulmonary rehabilitation when indicated

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specific DB program/Diaphragmatic manipulation program
Description: 12 weeks of 2 sessions/week: one session will be remote and one in-person
Study: NCT05824598

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multifunctional rehabilitation treatment
Description: multidisciplinary approach with (OMT, psychological counseling, and therapists dedicated to swallowing disorders)
Study: NCT04690465

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: Participants will receive a 16-week resistance training program, with 3 times a week (a total of 48 training sessions) and 60 minutes per session intervention, which is adopted from the 12-week resistance training program introduced in the book Growing Stronger: Strength Training for Older Adults (Seguin et al., 2002), with minor modifications under the advice of Physical Fitness Association of Hong Kong, China (PFA).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Eight-form Yang-style Tai Chi program
Description: The active concurrent control group will receive Eight-form Yang-style Tai Chi program which has been confirmed feasible and will be taught by the qualified coach.
Study: NCT05714969

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAK-755
Description: TAK-755 IV infusion

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TAK-755
Description: TAK-755 IV infusion
Study: NCT05091177

Intervention type: DIAGNOSTIC_TEST
Intervention: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation
Description: Use relevant instruments for inspection

Intervention type: DIAGNOSTIC_TEST
Intervention: Serum acetylcholine receptor antibody, erythrocyte deposition rate, hypersensitive C protein, neostigmine test,thymus CT, low frequency repeated nerve stimulation
Description: Use relevant instruments for inspection
Study: NCT06132542

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: stem cell therapy
Description: The fat derived stem cell will be transplanted by a reproductive gynecologist who does routine ovarian puncture.
Study: NCT01938196

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KWA-0711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KWA-0711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KWA-0711

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KWA-0711

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT05222880

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JJVC Investigational Multifocal Contact Lenses manufactured in senofilcon A C3
Description: TEST Lens
Study: NCT01244074

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: biofeedback training
Study: NCT05401565

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Balovaptan
Description: Intervention of oral administration of 10mg balovaptan QD for 12 weeks followed by two weeks of follow-up period

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo
Study: NCT05802017

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Allergen-specific substitute diet
Description: Substitution of IgG4 allergen-specific reactive foodstuffs for equivalent foodstuffs with similar nutritional value.
Study: NCT05486884

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maintain MAP ≥ 90 mmHg
Description: Maintain MAP ≥ 90 mmHg for the 24 hours following inclusion by perfusion of norepinephrine

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Maintain MAP ≥ 65 mmHg
Description: Maintain MAP ≥ 65 mmHg for 24 hours after randomization through the perfusion of norepinephrine
Study: NCT06108999

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Connettivina BIO cream and gauze
Description: Connettivina Bio cream and gauze-pad efficacy and tolerability will be evaluated in the management of acute or chronic wounds of different etiology, according to instruction for use. Only one wound per patient will be considered for the treatment according to the study protocol. The schedule treatment will consist on a daily medication changes, according to the instruction for use and the clinical practice, for a maximum of 7 Visits.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Connettivina BIO cream and gauze
Description: Connettivina Bio cream and gauze-pad efficacy and tolerability will be evaluated in the management of acute or chronic wounds of different etiology, according to instruction for use. Only one wound per patient will be considered for the treatment according to the study protocol. The schedule treatment will consist on a daily medication changes, according to the instruction for use and the clinical practice, for a maximum of 7 Visits.
Study: NCT05289700

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HBOT in Hyperbaric chamber
Description: HBOT is the administration of oxygen (FIO2 = 100%) at a pressure higher than atmospheric pressure (2 ATA). The pressure increase is achieved by introducing compressed air into the hyperbaric chamber. This study will use a hyperbaric chamber that is already marketed, licensed and used in other diseases.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Hyperbaric chamber for placebo
Description: Hyperbaric chamber is the same chamber used for HBOT, but here with a limited hyperpressure (1.3 ATA) and using ambient air (FIO2=0.21), with illusion of treatment in healthy volunteers. All other aspects of the procedure are identical to those of the intervention. As in the intervention arm, there will be a compression period (although shorter), of 5 min, followed by 85 min at 1.3 ATA, then a decompression period of 5 min (total duration of 95 min).
Study: NCT05344846

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Guided imagery
Description: The individuals in this group will be provided with guided imagery application. Guided imagery will be applied to the participants in the hospital environment 6-10 hours after the cesarean section. Afterwards, guided imagery application will be requested every day for two weeks.
Study: NCT05038930

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobilisation using the Sara Combilizer
Description: The mobilisation with the Sara Combilizer, will be done one time either 24 or 48 hours after stable intracranial pressure
Study: NCT00433472

Intervention type: DEVICE
Group type: OTHER
Intervention: magnetic resonance imaging (MRI)
Description: MRI scan to be complete to look at RSR13 on measurement of T2 and T2\* on MRI
Study: NCT06522750

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 7-day ambulatory caloric restriction intervention using the Buchinger-Wilhelmi method
Description: Buchinger-Wilhelmi method, will be administered in an ambulatory setting under physician guidance. It involves an initial bowel cleanse followed by 7-day fasting period. The initial bowel cleanse will be performed according to the standard procedure commonly used for colonoscopy preparation. During the fasting period, subjects will be provided with a dietary energy supply of a maximum of 350 kcal per day, primarily consisting of vegetable broths as well as fresh vegetable juices. Patients will only be allowed to consume calorie-free and unsweetened water or tea in addition to the prescribed diet.
Study: NCT03167554

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham comparator
Description: The electrolysis technique was simulated to be delivered. The guide tube of the needle contacted with the skin, located on the painful area, and the device remained switched on to simulate its functioning.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group 1
Description: Percutaneous Therapeutic Electrolysis (EPTE®) with monopolar needle, 330 microamps, 1 min 20 sec.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group 2
Description: Percutaneous Therapeutic Electrolysis (EPTE®) with bipolar needle, 120 microamps, 1 min 20 sec.
Study: NCT05446961

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: LCLT : 68% elemental L-carnitine and 32 % Tartric acid
Description: 3 g orally capsules

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: LCLT : 68% elemental L-carnitine and 32 % Tartric acid
Description: 3 g orally capsules

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: orally capsules

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: orally capsules
Study: NCT06085521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNK01001 Dose A
Description: Capsules taken orally
Study: NCT06433453

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin 50 MG
Description: The medication is commenced when a preovulatory follicle is observed. It will be administered for a minimum of one day, up to a maximum of 7 days. It will be discontinued when anovulation is observed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound scans
Description: Ultrasound scans done intermittently before and after an ovulatory or anovulatory event

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Finger prick blood test
Description: Capillary blood extracted from a finger prick. Blood spots are collected on a specialized card, dried and frozen before reproductive hormones are assayed from them.
Study: NCT06424470

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stapokibart
Description: Stapokibart Injection

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06433453

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Urine test
Description: Early morning urine tests to assay reproductive hormones
Study: NCT04842487

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R2-CHOP(Lenalidomide,Rituximab,cyclophosphamide，hydroxyldaunorubicin，Vincristine，Prednisone）)
Description: Lenalidomide：25mg po QN,d1-10 Rituximab: 375mg/m2, ivdrip, d1 Cyclophosphamide: 750mg/m2, iv or ivdrip, d1 Hydroxyldaunorubicin: 50mg/m2, iv or ivdrip, d1 Vincristine： 1.4 mg/m2 , iv（max：2mg）, d1 Prednisone: 60mg/m2, po, d1-5 every 3 weeks was a course of treatment
Study: NCT06085521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LNK01001 Dose B
Description: Capsules taken orally

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Capsules taken orally
Study: NCT06209073

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality exercise
Description: after explaining the treatment method for patients, the patients will perform full body aerobic exercise by applying kick boxing to destroy walls of rock; the patient moves most of body muscles in this game. He or she flex and extend the shoulder and the elbow with flexion and extension in the knee. squatting exercise, endurance exercise, coordination for arm and shoulder exercise will also performed in virtual reality
Study: NCT05713409

Intervention type: DIAGNOSTIC_TEST
Intervention: Intestinal ultrasound
Description: As part of the routine care, patients will undergo ileocolonoscopy at 6 months, IUS will be performed 3, 6, 12, 18, 24, 30 and 36 months (using B-mode and CDS) and at 3 and 6 months elastography will be performed on the neo-terminal ileum. Biomarkers (CRP and fecal calprotectine) will be measured according to routine care.
Study: NCT05749172

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength group
Description: 4 sets of strength training exercises with 10 repetitions determined from ACSM two days a week, with a minimum of 72 hours between these days. In this exercise protocol, the movements of back squat, seated leg extension, seated leg curls, machine hip adductions, machine hip abductions, standing calf raises, back lat pulldowns, seated rows, bench press, incline bench press, biceps curls, triceps pushdowns, back press, back extension, pushup, pullup, squats and sit-ups will be performed.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Controlled group
Description: Two hours of parkour training for two days a week.
Study: NCT06209073

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: the patients will receive conventional treatment in the form of aerobic exercise, resistance exercise and endurance exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional treatment
Description: the patients will receive conventional treatment in the form of aerobic exercise, resistance exercise and endurance exercise.
Study: NCT06204562

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: imitated laughter practice
Description: To imitate laughter, participants will practice Duchenne smile, which is reported to associate with positive emotion in people producing it If participants cannot imitate a Duchenne smile, they can hold a chopstick horizontally in their mouth tightly. To help timing the 3-minute and to enhance adherence, an audio recording with joyous music and vocal instruction will be played alongside the practice. Versions with or without laugh voice will be prepared for their preferences. A logbook will be given to each participant to record their practice. To remind participants to practise, a reminder will be made each day through the public announcement system of the respective nursing home, and the audio guide will be played.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: imitated laughter practice
Description: To imitate laughter, participants will practice Duchenne smile, which is reported to associate with positive emotion in people producing it If participants cannot imitate a Duchenne smile, they can hold a chopstick horizontally in their mouth tightly. To help timing the 3-minute and to enhance adherence, an audio recording with joyous music and vocal instruction will be played alongside the practice. Versions with or without laugh voice will be prepared for their preferences. A logbook will be given to each participant to record their practice. To remind participants to practise, a reminder will be made each day through the public announcement system of the respective nursing home, and the audio guide will be played.